Farhad Khosravi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Farhad khosravi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Farhad Khosravi Today - Breaking & Trending Today

Ocular Therapeutix (NASDAQ:OCUL) Upgraded at StockNews.com

StockNews.com upgraded shares of Ocular Therapeutix (NASDAQ:OCUL – Get Rating) from a sell rating to a hold rating in a research note released on Wednesday morning. OCUL has been the topic of a number of other reports. JMP Securities raised their price target on Ocular Therapeutix from $11.00 to $12.00 in a research note on […] ....

Robertw Baird , Amarpreets Sawhney , Swiss National Bank , Jpmorgan Chase Co , Panagora Asset Management Inc , Ocular Therapeutix Inc , Ocular Therapeutix , Get Rating , National Bank , Montreal Can , Asset Management , Cetera Investment Advisers , Investment Advisers , Farhad Khosravi , Ocular Therapeutix Daily ,

Ocular Therapeutix (NASDAQ:OCUL) Stock Rating Upgraded by StockNews.com

StockNews.com upgraded shares of Ocular Therapeutix (NASDAQ:OCUL – Get Rating) from a sell rating to a hold rating in a research note published on Wednesday morning. Several other equities research analysts have also weighed in on the company. JMP Securities lifted their price objective on Ocular Therapeutix from $11.00 to $12.00 in a report on […] ....

Borough Of Bedford , United Kingdom , Robertw Baird , Amarpreets Sawhney , Marshall Wace , Barclays Plc , Renaissance Technologies , Ocular Therapeutix Inc , Hermes Inc , Ocular Therapeutix Company Profile , Ocular Therapeutix , Get Rating , Farhad Khosravi , Ocular Therapeutix Daily ,

Ocular Therapeutix, Inc. (NASDAQ:OCUL) Sees Significant Growth in Short Interest

Ocular Therapeutix, Inc. (NASDAQ:OCUL – Get Rating) was the target of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 6,650,000 shares, a growth of 20.3% from the May 15th total of 5,530,000 shares. Based on an average trading volume of 977,800 shares, the […] ....

Robertw Baird , Amarpreets Sawhney , Jpmorgan Chase Co , Ameriprise Financial Inc , Geode Capital Management , Ocular Therapeutix Inc , Ocular Therapeutix , Get Rating , Therapeutix Trading Down , Street Group , Street Corp , Capital Management , Farhad Khosravi , Ocular Therapeutix Daily ,

Ocular Therapeutix (NASDAQ:OCUL) PT Raised to $12.00 at HC Wainwright

Ocular Therapeutix (NASDAQ:OCUL – Get Rating) had its target price boosted by HC Wainwright from $10.00 to $12.00 in a research note published on Tuesday, The Fly reports. A number of other research firms have also recently commented on OCUL. JMP Securities lifted their price objective on Ocular Therapeutix from $11.00 to $12.00 in a […] ....

Amarpreets Sawhney , Robertw Baird , Ocular Therapeutix Inc , Jpmorgan Chase Co , Swiss National Bank , Panagora Asset Management Inc , Ocular Therapeutix , Get Rating , Therapeutix Trading Down , National Bank , Montreal Can , Asset Management , Cetera Investment Advisers , Investment Advisers , Farhad Khosravi , Ocular Therapeutix Daily ,

Ocular Therapeutix (NASDAQ:OCUL) Upgraded at StockNews.com

Ocular Therapeutix (NASDAQ:OCUL – Get Rating) was upgraded by investment analysts at StockNews.com from a “sell” rating to a “hold” rating in a note issued to investors on Wednesday. A number of other research analysts have also recently weighed in on the company. Robert W. Baird lifted their price objective on Ocular Therapeutix from $10.00 […] ....

Dekabank Deutsche Girozentrale , Robertw Baird , Amarpreets Sawhney , Ocular Therapeutix Inc , Archford Capital Strategies , Ahrens Investment Partners , Mackenzie Financial Corp , Ocular Therapeutix , Get Rating , Financial Corp , Bank Deutsche Girozentrale , Investment Partners , Farhad Khosravi , Ocular Therapeutix Daily , Nasdaq Ocul , Stocknews Com ,